We performed a retrospective cohort study of all Type 1 cesarean scar pregnancies (n=18) or cervical pregnancies (n=5) at an academic tertiary center after treatment with a cervical double balloon catheter from 2018 to 2022 to evaluate outcomes and maternal morbidity. Cervical double balloon catheter treatment was associated with no cases (95% confidence interval 0-16%) of maternal hemorrhage treated with transfusion, hysterectomy, or ICU admission. Treatment was successfully performed by nine different obstetrics and gynecology specialists.

Original languageEnglish
Pages (from-to)993-995
Number of pages3
JournalObstetrics and gynecology
Issue number6
StatePublished - Dec 1 2022


Dive into the research topics of 'Maternal Morbidity After Double Balloon Catheter Management of Cesarean Scar and Cervical Pregnancies'. Together they form a unique fingerprint.

Cite this